watching and buying weakness
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
In TTNP starter with Sheff at 6.20...GL
Vert nice flag pattern...very very tight BB bands...this will likely move up sharply...Market makers need shares....up we go...GL
This ticker is looking more and more like one of the best investing opportunities with huge upside potential...check out last week's official SEC filing..."1%/12% Step-Up Senior Secured Third Lien Convertible Notes. The Company issued 4,344,959 new ordinary shares of the Company (the “New Shares”) and $750.0 million of 1%/12% Step-Up Senior Secured Third Lien Convertible Notes due 2030 (the “Convertible Notes”) to certain creditors holding approximately $2.5 billion of pre-petition secured debt claims. The New Shares issued to these creditors and the Convertible Notes may only be traded together and not separately. The Convertible Notes are convertible into New Shares in certain circumstances, at a conversion price (subject to adjustment in accordance with the terms of the Third Lien Indenture) which was $95.60 as of the issue date. The Third Lien Indenture includes customary covenants that restrict the granting of liens and customary events of default, including, among other things, failure to issue securities upon conversion of the Convertible Notes."
http://www.sec.gov/Archives/edgar/data/1465872/000156459016015692/ogil-10k_20151231.htm
..and again "VDC Note. Effective with the Company’s emergence from bankruptcy, VDC’s former equity interest in the Company was cancelled. Immediately following that event, the VDC Note was converted into 655,094 New Shares in accordance with the terms thereof, in satisfaction of the obligation thereunder, which, including accrued interest, totaled approximately $62.0 million as of such date."...divide $62 milly by 655,094 shares...huge upside officially filed late March 2016.
...granted there are lots of unknowns...but from current 0.017 to anywhere remotely close to $95.60...huge upside...I intend to add to my core shares this week...maybe buy another 500k / 1 milly shares...dont want to miss out on this complicated yet hugely profitable upside...yet I am willing to buy on the way up as well....GL...(I trade about 200K shares which is about 10% of my holdings of VTGDF)
WhatdoIknow...lol...we are steadily rising in pps.....I am holding a 2milly core till Dec 2016 and trading 10% to take advantage of Advantage's volatility.....GL
More volatility with this coming down the pipe:
Vantage Drilling International Schedules 2015 Earnings Release Date and Conference Call
HOUSTON, TX--(Marketwired - March 28, 2016) - Vantage Drilling International ("Vantage" or the "Company") today announced that it will conduct a call at 11:00 AM Eastern Time on March 30, 2016 to discuss operating results for 2015 and recent developments. Vantage will release earnings before the market opens on March 30, 2016. To access the conference call, U.S. callers may dial toll free 888-765-5570 and international callers may dial 913-312-0380. The pass code will be 8189541. Please call ten minutes ahead of time to ensure proper connection. A replay of the conference call will be available for two weeks following the call and can be accessed by dialing 888-203-1112 for U.S. callers and 719-457-0820 for international callers. The access code for the replay is 8189541.
About the Company
Vantage, a Cayman Islands exempted company, is an offshore drilling contractor, with an owned fleet of three ultra-deepwater drillships, the Platinum Explorer, the Titanium Explorer and the Tungsten Explorer and four Baker Marine Pacific Class 375 ultra-premium jackup drilling rigs. Vantage's primary business is to contract drilling units, related equipment and work crews primarily on a dayrate basis to drill oil and natural gas wells. Vantage also provides construction supervision services for, and will operate and manage, drilling units owned by others. Through its fleet of seven owned drilling units, Vantage is a provider of offshore contract drilling services globally to major, national and large independent oil and natural gas companies.
Only 4 million shares remain registered....volatility coming......
buy low sell high...or sell high and buy low...it is you against the algo-bots...super fast computers...have fun and GL.
...good luck to you...my buy actions speak to the profitable risk reward here...you are clearly uncomfortable with VTGDF...go find another good stock...I am trading about 12 to 15 tickers at any one time...eom...gl
...do some math...I communicated with Mr Su's lawyer several times...I really like the risk reward here...GL
bot a couple million shares over last two weeks...will add on more weakness...GL
From Yahoo message board:
SC 13G/A 02/16/2016/Conversion of notes into common shares for Anchorage Capital
This is why I am still in #VTGF! They converted over 3.3 million dollars of convertible notes into common shares for Anchorage Capital.
VANTAGE DRILLING CO filed this SC 13G/A on 02/16/2016
As of December 31, 2015, each of the Reporting Persons may be deemed the beneficial owner of approximately 0.4% of Shares outstanding. (There were 311,836,678 Shares outstanding as of October 23, 2015, according to the Issuer's Form 10-Q, filed November 9, 2015. Each of the Reporting Persons may be deemed the beneficial owner of approximately 1,381,475 Shares obtainable upon conversion of $3,300,000 of the Notes. Pursuant to Rule 13d-3(d)(1)(i)(D), such Shares have been added to the Issuer's number of Shares outstanding, for a total of approximately 313,218,153 Shares outstanding.)
http://finance.yahoo.com/mbview/threadview/?&bn=bff249bb-af2a-4f04-9141-f6f16147ed83&tid=1458206813110-0134d549-a3eb-4137-876d-cc97a45f075d&tls=la%2Cd%2C0%2C3
Large short position as well...!
Boom!...HUGE 100%+ blow out q...HUGE 100%+ increase in revs year over year ...up over 100% in revs!!!!..plus 70 million buy back starts today Feb 3 2016...
Fourth quarter revenue increased 108% year-over-year to $73.7 million
Fourth quarter net income of $13.7 million or $1.13 per diluted share
Record full year revenue increased 113% year-over-year to $264.9 million
Record full year net income of $47.2 million or $3.82 per diluted share
LOS ANGELES, Feb. 02, 2016 (GLOBE NEWSWIRE) -- Natural Health Trends Corp. (NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and "quality of life" products under the NHT Global brand, today announced its financial results for the fourth quarter and full year ended December 31, 2015.
Fourth Quarter 2015 Financial Highlights
Total revenue increased 108% to $73.7 million, compared to $35.4 million in the fourth quarter of 2014.
Revenue from the Company’s Hong Kong operations, which represented 92% of total revenue, increased 120% to $67.7 million, compared to $30.7 million in the fourth quarter of 2014.
Revenue outside of Hong Kong increased 27% to $5.9 million, compared to $4.7 million in the fourth quarter of 2014.
Operating income increased 129% to $13.9 million, compared to $6.1 million in the fourth quarter of 2014.
Net income available to common stockholders was $13.7 million, or $1.13 per diluted share, compared to $5.8 million, or $0.45 per diluted share, in the fourth quarter of 2014.
The number of Active Members1 increased 15% to 109,360 at December 31, 2015, compared to 94,700 at September 30, 2015.
1 Natural Health Trends defines Active Members as those that have placed at least one product order with the Company during the preceding twelve month period.
Full Year 2015 Financial Highlights
Total revenue increased 113% to $264.9 million, compared to $124.6 million for the full year of 2014.
Operating income increased 130% to $47.9 million, compared to $20.8 million for the full year of 2014.
Net income available to common stockholders was $47.2 million, or $3.82 per diluted share, compared to $20.4 million, or $1.61 per diluted share, for the full year of 2014.
http://finance.yahoo.com/news/natural-health-trends-reports-strong-210100412.html
Bot in twice here...average 18.25...gl...
Out temporarily at $51...+8.5%....back in later lower...gl
Bot starter in MHLD at $13.72...gl
Bot starter in CALM here at $47...gl
I will bid for VTGDF shares Monday/Tuesday in light of the following...if I trust a yahoo message board post...lol...risk reward ratio has changed a little bit...gl...:
http://finance.yahoo.com/mb/forumview/?&v=m&bn=bff249bb-af2a-4f04-9141-f6f16147ed83
"As some already know, Nobu Su, the largest shareholder of VTG hired attorneys to fight against some of the first day motions and the POR. The judge did not make any adverse rulings against his counsel (which in a way also represents all VTG shareholders) and also agreed to extend the deadline for filing an objection to the POR till next Tuesday.
One of the attorneys asked me to provide her with any information that I think could be useful for their objection. So if anyone has any information, please send to Deirdre Brown at "brown(at)hooverslovacek(dot)com".
I also reached out to the US trustee but it seems he's staying neutral for now and won't be objecting to the disclosure statement. Less"
bot again today...$14.30...target $20+...gl
bot in twice at $16...maybe too early...we'll see...gl
bot back in $10.45...gl
stopped out...
stopped out...
I dunno...maybe I should buy a few vtgdf...if the largest shareholder...100 million shares I recall...is fighting the chapter 11 reorganization ...maybe significant upside here....or if Petrobas loses $1 billion lawsuit to VTGDF...upside again...I intended to buy shares in the reorganized business model...gl
added RIGL at 2.83...gl
agreed...am in with a starter under $3 OPXA...gl
SSP et al: in your opinion and reflecting on your past trading experience, what are the best tools you have utilized to hedge long positions? How have you shorted the overall markets? How have you shorted particular sectors?
I have used DGAZ and LABD successfully...looking for some additional ideas that work as well or better...Happy 2016!...market volatility = trading system success.
Bot in rigl...$3.04....gl
Nice...profit is profit...waiting at 8.60's to reload...
...out for now...+15%...in lower later...gl
folks want cheap shares...
bot starter here...CLVS...$34.70...gl
5 different hedge funds just gobbled up 13% of cmrx...back into cmrx today around $8.35 near close...gl.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11084647
thanks...I know I will not get destroyed in skbi...too many big money hedgies i am a little familiar with still in skbi...lol...gl
bot starter in dgaz...$14.76...gl
...my buys are based on price action technicals AND company fundamentals for skbi...I do like their revenue growth and major holders...in short I like the risk reward here...
adding to skbi position...bot again at $0.53...target $1.03...gl
stopped out at 6.99...gl...
Chimerix Inc (NASDAQ: CMRX) shares are down more than 77 percent on Monday morning after the company issued a press release that revealed it has missed a primary endpoint on its Phase 3 trial of brincidofovir for patients with cytomegalovirus (CMV) infection.
Brincidofovir has been in development for several years, and received FDA Fast Track designation for CMV, smallpox and adenovirus in 2014. The drug became known for its use as an experimental Ebola treatment last year, but Chimerix ultimately opted to end those tests to focus on other diseases, including CMV.
According to Chimerix, its latest Phase 3 trial of brincidofovir was consistent with positive Phase 2 results in the first 14 weeks of the study. "However, during the 10 weeks off treatment from Week 14 to Week 24, there was an increase in CMV infections in the brincidofovir arm compared to the control arm," the company warned.
Michelle Berrey, the President and CEO of Chimerix, echoed this sentiment. ""While we are clearly disappointed in the top-line results from SUPPRESS, we remain committed to better understanding the full data set as we consider potential paths forward for brincidofovir," she said.
Berrey also gave some forward-looking statements, and highlighted the company's financials: "With a strong cash position, an experienced leadership team, and brincidofovir patent exclusivity through 2034, we continue to believe there is a viable path forward for the development of brincidofovir."
After closing the holiday-shortened week above $35 per share, Chimerix now trades near the $8 mark. The company went public in April 2013 at an initial price of $14 per share.
Morgan Stanley downgraded Chimerix in October to Equal-weight, while Janney Capital initiated coverage of the stock at Neutral in early December.
http://finance.yahoo.com/news/chimerix-ditched-ebola-treatment-focus-143027516.html Dec 28 2015
Bot in twice...avg 7.48...gl
Period Ending 30-Sep-14 30-Jun-14 31-Mar-14 31-Dec-13
Total Revenue 18,353 14,240 6,833 9,625
Cost of Revenue 9,590 7,881 4,009 4,906
Gross Profit 8,763 6,359 2,823 4,720
(all numbers times 1000)
Nice q over q growth in gross profit...37.8%.
http://finance.yahoo.com/q/is?s=skbi
bot starter at 1.37...gl...target 1.51 to 1.80...